Pioglitazone Accord الاتحاد الأوروبي - الإنجليزية - EMA (European Medicines Agency)

pioglitazone accord

accord healthcare s.l.u. - pioglitazone hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes - pioglitazone is indicated in the treatment of type-2 diabetes mellitus:as monotherapyin adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance.after initiation of therapy with pioglitazone, patients should be reviewed after 3 to 6 months to assess adequacy of response to treatment (e.g. reduction in hba1c). in patients who fail to show an adequate response, pioglitazone should be discontinued. in light of potential risks with prolonged therapy, prescribers should confirm at subsequent routine reviews that the benefit of pioglitazone is maintained.

Ivabradine Accord الاتحاد الأوروبي - الإنجليزية - EMA (European Medicines Agency)

ivabradine accord

accord healthcare s.l.u. - ivabradine hydrochloride - angina pectoris; heart failure - cardiac therapy - symptomatic treatment of chronic stable angina pectorisivabradine is indicated for the symptomatic treatment of chronic stable angina pectoris in coronary artery disease adults with normal sinus rhythm and heart rate ≥ 70 bpm.ivabradine is indicated :- in adults unable to tolerate or with a contra-indication to the use of beta-blockers- or in combination with beta-blockers in patients inadequately controlled with an optimal beta-blocker dose.treatment of chronic heart failureivabradine is indicated in chronic heart failure nyha ii to iv class with systolic dysfunction, in patients in sinus rhythm and whose heart rate is ≥ 75 bpm, in combination with standard therapy including beta-blocker therapy or when beta-blocker therapy is contraindicated or not tolerated. (see section 5.1)

Sitagliptin / Metformin hydrochloride Accord الاتحاد الأوروبي - الإنجليزية - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, type 2 - drugs used in diabetes - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin.it is indicated in combination with a sulphonylurea (i.e., triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a sulphonylurea.it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i.e., a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist.it is also indicated as add-on to insulin (i.e., triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Vildagliptin Accord 50 mg Tablets مالطا - الإنجليزية - Medicines Authority

vildagliptin accord 50 mg tablets

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - vildagliptin - tablet - vildagliptin 50 mg - drugs used in diabetes

Daptomycin Accordpharma 350 mg powder for solution for injection/infusion أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

daptomycin accordpharma 350 mg powder for solution for injection/infusion

accord healthcare ireland ltd. - daptomycin - powder for solution for injection/infusion - 350 milligram(s) - other antibacterials; daptomycin

Daptomycin Accordpharma 500 mg powder for solution for injection/infusion أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

daptomycin accordpharma 500 mg powder for solution for injection/infusion

accord healthcare ireland ltd. - daptomycin - powder for solution for injection/infusion - 500 milligram(s) - other antibacterials; daptomycin

Nevirapine Accord 400mg prolonged-release tablets مالطا - الإنجليزية - Medicines Authority

nevirapine accord 400mg prolonged-release tablets

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - nevirapine, anhydrous - prolonged-release tablet - nevirapine, anhydrous 400 mg - antivirals for systemic use

Silodosin Accord 4 mg hard capsules أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

silodosin accord 4 mg hard capsules

accord healthcare ireland ltd. - silodosin - capsule, hard - 4 milligram(s) - silodosin

Silodosin Accord 8 mg hard capsules أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

silodosin accord 8 mg hard capsules

accord healthcare ireland ltd. - silodosin - capsule, hard - 8 milligram(s) - silodosin